FDA clarifies its position on zero-nicotine and synthetic nicotine

FDA headquarters, MarylandRecent statements by the Food and Drug Administration (FDA) have begun to clear up the U.S. federal agency’s position on nicotine free e-liquids and synthetic nicotine, as a new regulatory report from ECigIntelligence explains.

According to court statements made by the FDA, some devices that truly contain no nicotine (or only synthetic nicotine) may not be subject to the deeming regulations, depending on the circumstances in which they are likely to be used.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    Some disposable, closed-system devices with zero-nicotine or synthetic nicotine e-liquids may also escape regulation as tobacco products if they meet certain further criteria.

    However, even if products currently fall outside the scope of the deeming rule, the FDA could choose to regulate them later, the ECigIntelligence report says.

    Author default picture

    Daniel Mollenkamp

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization